Session Datesort ascending
Using a CRISPR/Cas9 Mutagenesis Screen to Identify Genes that Regulate the Anti-Tumor Activity of Natural Killer T-Cells/Determining Clinical Severity and Molecular Profiles of Acute Chest Syndrome in Patients with Sickle Cell Disease 06/30/2022 - 8:00am to 9:00am CDT
Defining the Role of Chromatin Structure in the Evolution from Transient Abnormal Myelopoiesis to Acute Megakaryoblastic Leukemia 06/23/2022 - 8:00am to 9:00am CDT
Disrupting cMET-HGF Axis in Sarcoma to Improve HER2-targeted CAR T-cell Therapy/Protein Markers of Acute Myeloid Leukemia Subclones that Expand at Relapse: Investigation with Clinical Applications 06/16/2022 - 8:00am to 9:00am CDT
Nanotechnology-Enabled Assembly Lines for Gene and Cellular Therapy 05/26/2022 - 8:00am to 9:00am CDT
Evolution of Germline Cancer Genomics: From Rare Disorders to Precision Oncology Trials 05/12/2022 - 8:00am to 9:00am CDT
Reference Ranges and Health Inequity in Hematology 04/28/2022 - 8:00am to 9:00am CDT
Evaluating the Effects of Critical Metabolite Depletion in Rhabdomyosarcoma 04/21/2022 - 8:00am to 9:00am CDT
Understanding Therapeutic Vulnerabilities in Patients with Ewing Sarcoma and Compromised DNA Damage Repair 04/14/2022 - 8:00am to 9:00am CDT
The Clot Thickens: Hemostasis and Thrombosis Clinical Research Originating from Clinical Conundrums 04/07/2022 - 8:00am to 9:00am CDT
Lessons Learned Through Collaboration in Advanced Soft Tissue Sarcoma 03/31/2022 - 8:00am to 9:00am CDT

Pages